Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94M Sell
1,035,789
-34,061
-3% -$3.11M 0.41% 50
2026
Q1
$110M Sell
1,069,850
-65,035
-6% -$7.34M 0.54% 44
2025
Q4
$142M Buy
+1,134,885
New +$145M 0.67% 28
2025
Q1
$174M Sell
1,309,315
-56,137
-4% -$7.14M 0.93% 16
2024
Q4
$154M Sell
1,365,452
-151,393
-10% -$17.5M 0.79% 22
2024
Q3
$173M Sell
1,516,845
-19,297
-1% -$2.12M 0.83% 19
2024
Q2
$160M Buy
1,536,142
+12,792
+0.8% +$1.36M 0.81% 21
2024
Q1
$173M Buy
1,523,350
+24,670
+2% +$2.83M 0.87% 20
2023
Q4
$165M Buy
1,498,680
+19,496
+1% +$1.95M 0.86% 20
2023
Q3
$143M Sell
1,479,184
-197,156
-12% -$20.7M 0.82% 22
2023
Q2
$170M Hold
1,676,340
0.96% 14
2023
Q1
$170M Sell
1,676,340
-56,922
-3% -$6.01M 0.96% 14
2022
Q4
$190M Buy
1,733,262
+308,787
+22% +$32M 1.12% 8
2022
Q3
$138M Sell
1,424,475
-202,573
-12% -$21.6M 0.87% 15
2022
Q2
$177M Buy
1,627,048
+278,957
+21% +$31.7M 1.04% 10
2022
Q1
$160M Buy
1,348,091
+28,416
+2% +$3.52M 0.78% 20
2021
Q4
$186M Sell
1,319,675
-5,159
-0.4% -$660K 0.88% 18
2021
Q3
$157M Buy
1,324,834
+258
+0% +$31.7K 0.81% 19
2021
Q2
$154M Buy
1,324,576
+11,991
+0.9% +$1.4M 0.79% 20
2021
Q1
$157M Buy
1,312,585
+91,965
+8% +$10.9M 0.85% 19
2020
Q4
$134M Sell
1,220,620
-37,418
-3% -$4.07M 0.74% 22
2020
Q3
$137M Buy
1,258,038
+15,066
+1% +$1.53M 0.82% 21
2020
Q2
$114M Buy
1,242,972
+22,566
+2% +$2.04M 0.69% 29
2020
Q1
$106M Hold
1,220,406
0.48% 47
2019
Q4
$106M Buy
1,220,406
+32,253
+3% +$2.7M 0.48% 47
2019
Q3
$99.4M Sell
1,188,153
-79,688
-6% -$6.77M 0.45% 51
2019
Q2
$107M Sell
1,267,841
-43,235
-3% -$3.4M 0.47% 48
2019
Q1
$105M Sell
1,311,076
-5,558
-0.4% -$414K 0.47% 46
2018
Q4
$95.2M Sell
1,316,634
-13,279
-1% -$933K 0.46% 51
2018
Q3
$97.6M Sell
1,329,913
-10,884
-0.8% -$715K 0.39% 56
2018
Q2
$81.8M Sell
1,340,797
-220,303
-14% -$13.4M 0.36% 60
2018
Q1
$89.1M Hold
1,561,100
0.37% 64
2017
Q4
$89.1M Sell
1,561,100
-13,137
-0.8% -$728K 0.37% 64
2017
Q3
$84M Sell
1,574,237
-4,172
-0.3% -$209K 0.37% 66
2017
Q2
$70.1M Hold
1,578,409
0.33% 75
2017
Q1
$70.1M Sell
1,578,409
-136,131
-8% -$5.89M 0.33% 75
2016
Q4
$65.9M Buy
1,714,540
+138,855
+9% +$5.51M 0.36% 67
2016
Q3
$66.6M Sell
1,575,685
-31,281
-2% -$1.34M 0.38% 58
2016
Q2
$63.2M Sell
1,606,966
-32,908
-2% -$1.31M 0.38% 58
2016
Q1
$68.6M Buy
1,639,874
+111,958
+7% +$4.44M 0.44% 44
2015
Q4
$68.6M Sell
1,527,916
-5,707
-0.4% -$252K 0.47% 49
2015
Q3
$61.7M Sell
1,533,623
-17,176
-1% -$810K 0.45% 46
2015
Q2
$76.1M Sell
1,550,799
-4,739
-0.3% -$228K 0.55% 27
2015
Q1
$72.1M Sell
1,555,538
-60,787
-4% -$2.79M 0.53% 32
2014
Q4
$72.8M Sell
1,616,325
-26,463
-2% -$1.15M 0.57% 29
2014
Q3
$68.3M Sell
1,642,788
-1,372
-0.1% -$58K 0.6% 30
2014
Q2
$67.2M Buy
1,644,160
+109,161
+7% +$4.29M 0.6% 31
2014
Q1
$59.1M Sell
1,534,999
-82,231
-5% -$3.17M 0.55% 38
2013
Q4
$62M Sell
1,617,230
-6,116
-0.4% -$225K 0.63% 31
2013
Q3
$53.9M Buy
1,623,346
+150,821
+10% +$5.29M 0.64% 33
2013
Q2
$51.4M Buy
+1,472,525
New +$54M 0.64% 35

Other funds holding ABT

Glenmede Trust's ABT Position: Q2 2026 in Review

Glenmede Trust reduced its Abbott (ABT) stake by 3.2% in Q2 2026, selling an estimated $3.11M and leaving 1,035,789 shares worth $94M. The position accounts for 0.41% of the portfolio, ranked #50.

Glenmede Trust first reported a position in ABT in Q2 2013 and has held it in 51 quarters since. The position peaked at $190M in Q4 2022. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Glenmede Trust held 1,035,789 shares of Abbott worth $94M as of Q2 2026.
  • Glenmede Trust sold 34,061 Abbott shares in Q2 2026, an estimated $3.11M.
  • Abbott made up 0.41% of Glenmede Trust's portfolio in Q2 2026, its #50 holding.
  • Glenmede Trust first reported a position in Abbott in Q2 2013 and has held it in 51 quarters since.
  • Glenmede Trust's Abbott position peaked at $190M in Q4 2022.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.